Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients
Article Abstract:
The study conducted to investigate the safety and efficacy of peginterferon alfa-2b plus ribavirin against standard interferon alfa-2b plus ribavirin in HIV-HCV (hepatitis C virus) coinfected patients is presented. It is found that in combination with ribavirin, treatment with peginteferon alfa-2b is more effective than standard interferon alfa-2b for HCV infection in HIV-infected patients.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to Interferon: A Meta-analysis of Randomized Trials,
Article Abstract:
Ribavirin and interferon appear to be more effective than interferon alone for treating hepatitis C that has not responded to interferon, according to 12 trials covering 941 patients. However, less than 20% of the patients responded to combination therapy, indicating that more effective treatments are needed.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Nonresponse to Interferon in Chronic Hepatitis C: Re-treatment Redux
Article Abstract:
Interferon alpha and ribavirin together may be beneficial for treating patients with hepatitis C who do not respond to interferon alone. Even if drug treatment does not substantially inhibit the hepatitis C virus, it may still reduce liver damage in many patients.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Interferon-alpha for chronic hepatitis C: reducing the uncertainties. Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
- Abstracts: Impact of an educational program on efficacy and adherence with a twice-daily Lamivudine/Zidovudine/Abicavir regimen in underrepresented HIV-infected patients
- Abstracts: Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? Periodontal Disease and Coronary Heart Disease Risk
- Abstracts: Bioimpedance analysis and resting energy expenditure in undernourished and refed anorectic patients. Differences in resting energy expenditure between black and white smokers: implications for postcessation weight gain
- Abstracts: Managing venous disease with red wine leaf extract. Using honey as a dressing for infected skin lesions. The management of skin maceration